Offer - Urjas Oil for just ₹ 1
Spectrazid 250 Mg Injection is a prescription drug, available for use as Injection. Primarily, it is used for the treatment of Skin Infections, Pneumonia. Spectrazid 250 Mg Injection also has some secondary and off-label uses. These are listed below.
The optimal dosage of Spectrazid 250 Mg Injection is largely dependent on the individual's body weight, medical history, gender and age. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Detailed information has been provided in the dosage section.
While these are the most often observed Spectrazid 250 Mg Injection side effects, there are can be others also. These have been listed below. Normally, these side effects of Spectrazid 250 Mg Injection are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, Spectrazid 250 Mg Injection's effect is Safe during pregnancy and Safe for lactating mothers. It is important to know if Spectrazid 250 Mg Injection has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Spectrazid 250 Mg Injection related warnings section.
Spectrazid 250 Mg Injection is not recommended if you suffer from certain medical conditions as it can have adverse effects. Kidney Disease are examples of such conditions. Other conditions have been mentioned below in the Spectrazid 250 Mg Injection contraindications section.
Besides this, Spectrazid 250 Mg Injection may also have severe interaction with some medicines. Refer to the list below for further details.
You should also be aware that Spectrazid 250 Mg Injection is not safe while driving, and is not addiction.
Spectrazid 250 Mg Injection is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Infant (1 month to 2 years) |
|
Neonates (0 to 1 month) |
|
Is the use of Spectrazid 250 Mg Injection safe for pregnant women?
There are no side effects of Spectrazid in pregnant women.
Is the use of Spectrazid 250 Mg Injection safe during breastfeeding?
Spectrazid is completely safe for breastfeeding women.
What is the effect of Spectrazid 250 Mg Injection on the Kidneys?
Spectrazid rarely harms the kidneys.
What is the effect of Spectrazid 250 Mg Injection on the Liver?
Spectrazid does not damage the liver.
What is the effect of Spectrazid 250 Mg Injection on the Heart?
There are no any side effects of Spectrazid for the heart.
If you are suffering from any of the following diseases, you should not take Spectrazid 250 Mg Injection unless your doctor advises you to do so -
Is this Spectrazid 250 Mg Injection habit forming or addictive?
No, you will not get addicted to Spectrazid 250 Mg Injection.
Is it safe to drive or operate heavy machinery when consuming?
After taking Spectrazid 250 Mg Injection you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, but take Spectrazid 250 Mg Injection only as per medical advice.
Is it able to treat mental disorders?
No, the use of Spectrazid 250 Mg Injection in mental disorders is not effective.
Interaction between Food and Spectrazid 250 Mg Injection
It is safe to take Spectrazid 250 Mg Injection with food.
Interaction between Alcohol and Spectrazid 250 Mg Injection
It is difficult to say anything about the effect of Spectrazid 250 Mg Injection and alcohol. No research has been done on this yet.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; FORTAZ® (ceftazidime)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 728
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-312